BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806X952. A total of 4 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,444 | +100.6% | 282,300 | +30.9% | 0.01% | +100.0% |
| Q2 2023 | $3,710 | -65.5% | 215,700 | -66.7% | 0.00% | -66.7% |
| Q1 2023 | $10,753 | +17527.9% | 648,600 | +7907.4% | 0.01% | – |
| Q4 2022 | $61 | -100.0% | 8,100 | -67.3% | 0.00% | – |
| Q3 2022 | $246,000 | +5.1% | 24,800 | -3.9% | 0.00% | – |
| Q2 2022 | $234,000 | +120.8% | 25,800 | +145.7% | 0.00% | – |
| Q1 2022 | $106,000 | -92.8% | 10,500 | -88.1% | 0.00% | -100.0% |
| Q4 2021 | $1,476,000 | +1266.7% | 88,500 | +5105.9% | 0.00% | – |
| Q3 2021 | $108,000 | +4.9% | 1,700 | 0.0% | 0.00% | – |
| Q2 2021 | $103,000 | -67.8% | 1,700 | +3169.2% | 0.00% | -100.0% |
| Q1 2021 | $320,000 | +814.3% | 52 | +940.0% | 0.00% | – |
| Q4 2020 | $35,000 | -80.1% | 5 | -89.4% | 0.00% | – |
| Q3 2020 | $176,000 | +4.1% | 47 | -9.6% | 0.00% | – |
| Q2 2020 | $169,000 | -37.9% | 52 | -44.7% | 0.00% | – |
| Q1 2020 | $272,000 | – | 94 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 174,600 | $4,604,202 | 0.02% |
| SIMPLEX TRADING, LLC | 282,300 | $7,444 | 0.01% |
| JANE STREET GROUP, LLC | 118,300 | $3,119,571 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |